Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy
Year: 2022
Type: article
Source: Blood
Authors: Jorge E. Cortes, Tapan Saikia, Dong-Wook Kim, Yesid Alvarado, Franck E. Nicolini, Krishnakumar Rathnam, Navin Khattry, Sachin Punatar, Jane F. Apperley, Aude Charbonnier, Michael Deininger, Hugues de Lavallade, Nikki Granacher, Carlo Gambacorti-Passerini, Alessandro Lucchesi, Michael Mauro, Peter Vandenberghe, Gregor Verhoef, Andrew R. Whiteley, Arijit Nag, Shashikant Apte, Siu-Long Yao, Sandeep Inamdar, Ruchika Irene Dillu, Jayasree Sreenivasan, Geetanjali Chimote
Institutions: Prince Aly Khan Hospital, Eulji University Uijeongbu Eulji Medical Center, The University of Texas MD Anderson Cancer Center, Hôpital Lyon Sud, Meenakshi Mission Hospital and Research Centre, Tata Memorial Hospital, Advanced Centre for Treatment, Research and Education in Cancer, Hammersmith Hospital, Imperial College London, Institut Paoli-Calmettes, University of Utah, King's College Hospital, Ziekenhuisnetwerk Antwerpen Stuivenberg, University of Milano-Bicocca, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Memorial Sloan Kettering Cancer Center, KU Leuven, Universitair Ziekenhuis Leuven, Baylor University Medical Center, Tata Medical Center, Sahyadri Hospital, Sun Pharma Advanced Research (India)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310161895